|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,858.00 GBX | +2.24% |
|
+0.41% | +0.49% |
| 08:32pm | AstraZeneca hails phase 3 trial results of inhibitor Ultomiris | AN |
| 05:43pm | Bernstein Sees Upside Potential in AstraZeneca's Non-oncology Pipeline After Fireside Chat | MT |
Other languages
Search
No results for this search
Filters
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Other languages
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















